yup, Hope knows her stuff....only prob there is they are both in phase 1 or animal trials still, so both a long ways off.
One I'm watching is Inovio, a toltally non toxic vaccine that wipes out 99% of the virus...chemo would follow...
in an ideal world, it would be something like bavituximab that hones in more specifically on viral RNA and does less damage to surrounding RNA,
I'd like to see them do an electopolation vaccine and mop up with a non toxic...
actually there was chatter about dropping the INF this year, and some studies showing it might be doable soon.
the issue with all these things in the pipeline is they are all going to take a while if they even do pass muster. Most of the trials are stopped due to toxicity issues before they get too far into the process...and the ones that do pass muster still have a long approval process to go through.
If you need to treat in the next couple of years it would be best to check out the PI class drugs, 2 of which should be released in about a year.
If you are stage 1 or recently infected, than by all means follow the research and wait a while to treat...current SOC is far from ideal.
mb
yahoo..... thanks all for your information
Merryb is correct bout the monoclonal anti bodies, one such is bavituximab by peregrine google it there's been a lot happening with it. As far as I can tell it's 4 or 5 years into trials. Also check out chronvac c it's a theraputic vaccine by a company called triptep. And there is a new one, by a Danish company called santaris the drug has no name as of yet just a number. It targets mini RNA it's going to start human trials this year show great results on chimps ( the only other animal effected by hep c) and worked even after dosing had finished. With no apparent viral resistance as of yet
if you are referencing monoclonal antibodies they are still in trials now. Not due particularly soon.